Isis Awarded $6M CDC Grant for Development of Diagnostics for Infectious Disease

Oct 07, 2003

NEW YORK, Oct. 7 (GenomeWeb News) - Isis Pharmaceuticals said today it has received a three-year grant of up to $6 million from the US Centers for Disease Control and Prevention to develop an RNA-based diagnostic technology for human and animal infectious diseases as well as biodefense.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu